Skip to main content
Log in

Two novel JAK2 exon 12 mutations in JAK2V617F-negative polycythaemia vera patients

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2

References

  1. Kaushansky K . The chronic myeloproliferative disorders and mutation of JAK2: Dameshek's 54-year-old speculation comes of age. Best Pract Res Clin Haematol 2007; 20: 5–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Jamieson CH, Gotlib J, Durocher JA, Chao MP, Mariappan MR, Lay M et al. The JAK2V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation. PNAS 2006; 103: 6224–6229.

    Article  CAS  PubMed  Google Scholar 

  3. Pardanani AD, Levine RL, Lasho T, Pikman Y, Mesa RA, Wadleigh M et al. MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients. Blood 2006; 108: 3472–3476.

    Article  CAS  Google Scholar 

  4. Scott LM, Tong W, Levine M, Scott MA, Beer PA, Stratton MR et al. JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis. NEJM 2007; 356: 459–468.

    Article  CAS  PubMed  Google Scholar 

  5. Pardanani A, Lasho TL, Finke C, Hanson CA, Tefferi A . Prevalence and clinicopathologic correlates of JAK2 exon 12 mutations in JAK2V617F-negative polycythemia vera. Leukemia 2007; Epub ahead of print (June 28): 1–4.

  6. Baxter E, Scott L, Campbell P, East C, Fourouclas N, Swanton S et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 2005; 365: 1054–1061.

    Article  CAS  Google Scholar 

  7. Tefferi A, Thiele J, Orazi A, Kvasnicka HM, Barbui T, Hanson CA et al. Proposals and rationale for revision of the World Health Organisation diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood 2007; 110: 1092–1097.

    Article  CAS  PubMed  Google Scholar 

  8. Larsen TS, Christensen JH, Hasselbalch HC, Pallisgaard N . The JAK2V617F mutation involves B- and T-lymphocyte lineages in a subgroup of patients with Philadelphia-chromosome negative chronic myeloproliferative disorders. BJH 2007; 136: 745–751.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R J D'Andrea.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Butcher, C., Hahn, U., To, L. et al. Two novel JAK2 exon 12 mutations in JAK2V617F-negative polycythaemia vera patients. Leukemia 22, 870–873 (2008). https://doi.org/10.1038/sj.leu.2404971

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2404971

  • Springer Nature Limited

This article is cited by

Navigation